Patrick Wespi1, Jonas Steinhauser1, Grzegorz Kwiatkowski 1, and Sebastian Kozerke1
1Institute for Biomedical Engineering, University and ETH Zurich, Zurich, Switzerland
Synopsis
Spectroscopy is widely used in hyperpolarized metabolic
experiments due to its simplicity and robustness. In this work, it is shown
that with spectroscopic acquisition in rat hearts, the cardiac lactate
production is overestimated due to liver metabolism of [1-13] pyruvate. It is
demonstrated that this overestimation can be addressed using spatially resolved
data.
Introduction
Dissolution Dynamic Nuclear Polarization (DNP) is a
promising tool to study cardiac metabolism1. Spectroscopic acquisitions
have been used in many studies due their simple implementation and robustness
against frequency offsets and B0 inhomogeneity. Localization is
typically performed with either slice selection or surface coil positioning.
The lack of spatial resolution in spectroscopy makes it however impossible to
separate signal contributions from different compartments (e.g. blood pool and
myocardium in the heart). The liver produces lactate from hyperpolarized
pyruvate2 and this lactate pool is
partly released into the blood stream, flows to other organs and contributes to the
detected hyperpolarized lactate in these other organs. In this work, it is
shown that lactate produced by the liver contaminates the signal detected in the
heart. Selective lactate saturation in the liver is used to quantify this contamination.
Spectroscopic acquisition is compared to metabolic imaging using a dedicated
sequence that allows interleaved acquisition during the same experiment.Methods
Experiments were carried out on a Bruker BioSpec 9.4T system. All animal experiments were performed in adherence
to the Swiss Animal Protection law. A RF saturation pulse
(length 10.5ms) was implemented to allow for selective lactate saturation in
the liver (Figure 1). The pulse was tested in an imaging experiment with an
axial slice through the liver (Figure 2). Imaging was performed with a multi-echo
single-shot EPI acquisition3 at 1.25x1.25x3.5 mm3 resolution. Six healthy Sprague
Dawley rats were then used to compare cardiac slice-selective spectroscopy with
cardiac metabolic imaging. Each rat received two injections of hyperpolarized
[1-13C] pyruvate separated by 20 minutes. Hyperpolarization was performed with
a home-built DNP polarizer.4 One scan was performed with
liver lactate saturation and the other without. The order of the two scans was
randomized. Interleaved slice-selective spectroscopy and imaging was
implemented as shown in Figure 1c with a TR ≈ 1.2 sec. Spectroscopic data were quantified using
Amares in jMRUI. Imaging data were segmented with three regions of interest: 1)
whole left ventricle (LV), 2) LV blood pool and 3) LV myocardium. Both
spectroscopic and imaging data were integrated along time to obtain the area-under-the-curve
(AUC)5 of signal-time curves and
metabolite ratios were calculated. Statistical significance of the difference of metabolite
ratios between scans with and without liver lactate saturation was determined using
repeated measures ANOVA.Results
The imaging data of the liver (Figure 2) show that without
saturation, the liver produces relatively high amounts of lactate, which can be
suppressed using the saturation pulse. Figure 3 shows example spectra acquired from
the heart with and without liver lactate saturation. Figure 4 shows example
imaging data acquired from the heart with and without liver lactate saturation.
Figure 5 compares the metabolite ratios obtained from spectroscopic and imaging
data for the cases with and without liver lactate saturation, respectively. When
using liver lactate saturation, there is a significant reduction of lactate in cardiac spectroscopy, as well as of the whole left-ventricular (LV) lactate
in imaging and the LV blood pool lactate in imaging, however not of the LV myocardial
lactate (Figure 5).Discussion
24 ± 5% of the lactate signal in cardiac slice-selective spectroscopy was
found to originate from
lactate that was produced by the liver and flowed to the heart. Therefore, changes in liver metabolism will compromise
cardiac spectroscopic data and might be wrongly attributed to changes in
cardiac metabolism. Cases that have been studied with hyperpolarized pyruvate
include fasted and fed states of the subject2, metabolic diseases such as
diabetes6 and systemic administration
of drugs7, all of which can be expected
to affect the metabolism of multiple organs simultaneously. It is therefore
crucial to separate the signal originating from different organs in order to
establish accurate metabolic data of the heart.
Since imaging allows distinguishing between spatial compartments,
it should be preferred over spectroscopy. Liver lactate saturation was not
found to affect the myocardial lactate signal in imaging data significantly,
however there might still be some contamination of liver lactate into the
myocardium due to signal spilling from the blood pool as result of the spatial
point-spread function. Therefore, saturation of unwanted signal should be
considered for metabolic studies.Conclusion
Liver metabolism leads to statistically significant
overestimation of lactate detected in slice-selective spectroscopy experiments
in the heart. Imaging allows separating the blood pool from the myocardium and
should therefore be preferred. Saturation of unwanted signal should be
considered for future metabolic studies.Acknowledgements
The authors acknowledge funding from the Swiss National
Science Foundation, grant 320030_153014.References
1. Schroeder MA, Clarke K, Neubauer S, Tyler DJ. Hyperpolarized Magnetic Resonance A Novel Technique for the In Vivo Assessment of Cardiovascular Disease. Circulation 2011;124:1580–1594.
2. Hu S, Chen AP, Zierhut ML, Bok R, Yen Y-F, Schroeder MA, Hurd RE, Nelson SJ, Kurhanewicz J, Vigneron DB. In Vivo Carbon-13 Dynamic MRS and MRSI of Normal and Fasted Rat Liver with Hyperpolarized 13C-Pyruvate. Mol Imaging Biol 2009;11:399.
3. Sigfridsson A, Weiss K, Wissmann L, Busch J, Krajewski M, Batel M, Batsios G, Ernst M, Kozerke S. Hybrid multiband excitation multiecho acquisition for hyperpolarized 13C spectroscopic imaging. Magn Reson Med 2015;73:1713–1717.
4. Krajewski M, Wespi P, Busch J, Wissmann L, Kwiatkowski G, Steinhauser J, Batel M, Ernst M, Kozerke S. A multisample dissolution dynamic nuclear polarization system for serial injections in small animals. Magn Reson Med 2017;77:904–910.
5. Hill DK, Orton MR, Mariotti E, et al. Model Free Approach to Kinetic Analysis of Real-Time Hyperpolarized 13C Magnetic Resonance Spectroscopy Data. PLoS ONE 2013;8:e71996.
6. Le Page LM, Ball DR, Ball V, Dodd MS, Miller JJ, Heather LC, Tyler DJ. Simultaneous in vivo assessment of cardiac and hepatic metabolism in the diabetic rat using hyperpolarized MRS. NMR Biomed 2016;29:1759–1767.
7. Lewis AJM, Miller JJJ, McCallum C, Rider OJ, Neubauer S, Heather LC, Tyler DJ. Assessment of Metformin-Induced Changes in Cardiac and Hepatic Redox State Using Hyperpolarized[1-13C]Pyruvate. Diabetes 2016;65:3544–3551.